PhRMA Teams Up With Chinese Trade Group To Focus On IP Rights, Data Protection
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Pharmaceutical and Research Manufacturers of America (PhRMA) and the China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA) signed a cooperation framework in November to establish a regular dialogue between the two organizations
You may also be interested in...
Merck Powering Up In Emerging Markets Through Alliance And Pricing Strategies
As Merck looks to expand its geographic footprint in emerging markets, local players with extensive distribution networks will be the focus for partnerships, Merck Chief Strategy Officer and former Emerging Markets R&D Head Mervyn Turner told investors at the CLSA Emerging Markets Pharma Conference Dec.1 in New York
China's NDRC Releases First Set Of Price Cuts; MNCs See Deepest Cuts As Expected
SHANGHAI - China's National Development and Reform Commission has released long-awaited price cuts that will mostly affect multinational pharma companies
BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City
SHANGHAI - BIO, the largest biotechnology organization with 1,200 members around the world, announced its first two members from China - Zhangjiang Hi-tech Park in Shanghai and China Medical City in Taizhou - during the group's annual convention in Chicago